Resultados de la búsqueda 131-140 of 2121 for Maximum

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of part one of this study is to determine the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and safety profile of Q901 ...

  6. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine the maximum tolerated dose (MTD) of sonidegib in combination with pembrolizumab in participants with advanced solid ...

  7. Salud del adulto Noticias de la Mayo Clinic

    Infórmate sobre la salud del adulto, incluyendo salud física y mental y problemas en las relaciones y el trabajo.

  8. Hematología - Ensayos clínicos - Mayo Clinic

    The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); in the absence of exceeding the MTD of ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 and characterize its dose-limiting toxicities (DLTs) when given daily ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); in the absence of exceeding the MTD of ...